Thymosin α1 suppresses migration and invasion of PD-L1 high-expressing non-small-cell lung cancer cells via inhibition of STAT3–MMP2 signaling

BACKGROUND: Thymosin α1 (Tα1) is one of the most commonly used immunomodulators for metastatic non-small-cell lung cancer (NSCLC) patients in many countries. Despite the identification of the direct suppression on cancer cell proliferation, little is known about its effect on metastasis and metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Bo, Cong, Wu, Qiang, Zhao, Hai, Li, Xuebing, Zhou, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205819/
https://www.ncbi.nlm.nih.gov/pubmed/30425517
http://dx.doi.org/10.2147/OTT.S177943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205819/
https://www.ncbi.nlm.nih.gov/pubmed/30425517
http://dx.doi.org/10.2147/OTT.S177943

Ejemplares similares